THEMISMED — Themis Medicare Cashflow Statement
0.000.00%
- IN₹9.58bn
- IN₹10.42bn
- IN₹3.42bn
Annual cashflow statement for Themis Medicare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 953 | 725 | 534 | 397 | 19.3 |
| Depreciation | |||||
| Non-Cash Items | -97.2 | -105 | -137 | 9.65 | -70.7 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -606 | -565 | -299 | -159 | -84.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 344 | 161 | 221 | 347 | -32.7 |
| Capital Expenditures | -206 | -287 | -184 | -154 | -48.7 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 50.4 | 47.9 | 24.7 | 32.5 | 23.3 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -156 | -240 | -159 | -122 | -25.4 |
| Financing Cash Flow Items | -65.4 | -79.9 | -76.3 | -84.9 | -88.9 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -175 | 1.36 | -87.7 | -259 | 37.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 12.6 | -77.3 | -26.2 | -33.6 | -20.2 |